Cited 13 time in
Solid-Phase Synthesis of 1,3,4-Thiadiazole Derivatives via Desulfurative Cyclization of Thiosemicarbazide Intermediate Resin
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yang, Seung-Ju | - |
| dc.contributor.author | Choe, Ji-Hye | - |
| dc.contributor.author | Gong, Young-Dae | - |
| dc.date.accessioned | 2024-08-08T01:02:09Z | - |
| dc.date.available | 2024-08-08T01:02:09Z | - |
| dc.date.issued | 2016-08 | - |
| dc.identifier.issn | 2156-8952 | - |
| dc.identifier.issn | 2156-8944 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/14917 | - |
| dc.description.abstract | A 1,3,4-thiadiazole library was constructed by solid phase organic synthesis. The key step of this solid-phase synthesis involves the preparation of polymer-bound 2-amido-5-amino-1,3,4-thiadiazole resin by the cyclization of thiosemicarbazide resin using p-TsC1 as the desulfurative agent, followed by the functionalization of the resin by alkylation, acylation, alkylation/acylation, and Suzuki coupling reactions. Both the alkylation and acylation reactions chemoselectively occurred at the 2-amide position of 2-amido-5-amino-1,3,4-thiadiazole resin and the 5-amine position of 2-amido5-amino-1,3,4-thiadiazole resin, respectively. Finally, these functionalized 1,3,4-thiadiazole resins were treated with trifluoroacetic acid in dichloromethane, affording diverse 1,3,4-thiadiazole analogs in high yields and purifies. The 1,3,4-thiadiazole analogs show a different distribution of physicochemical and biological properties compared with our previously constructed 1,3,4-oxadiazole and 1,3,4-thiadiazole libraries in a range of orally available drug properties. | - |
| dc.format.extent | 8 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | AMER CHEMICAL SOC | - |
| dc.title | Solid-Phase Synthesis of 1,3,4-Thiadiazole Derivatives via Desulfurative Cyclization of Thiosemicarbazide Intermediate Resin | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1021/acscombsci.6b00071 | - |
| dc.identifier.scopusid | 2-s2.0-84981278115 | - |
| dc.identifier.wosid | 000381231500009 | - |
| dc.identifier.bibliographicCitation | ACS COMBINATORIAL SCIENCE, v.18, no.8, pp 499 - 506 | - |
| dc.citation.title | ACS COMBINATORIAL SCIENCE | - |
| dc.citation.volume | 18 | - |
| dc.citation.number | 8 | - |
| dc.citation.startPage | 499 | - |
| dc.citation.endPage | 506 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
| dc.subject.keywordPlus | REAGENT-BASED CYCLIZATION | - |
| dc.subject.keywordPlus | SUBSTITUTED 1,3,4-THIADIAZOLES | - |
| dc.subject.keywordPlus | ANTIHYPERTENSIVE THIADIAZOLES | - |
| dc.subject.keywordPlus | 1,3,4-OXADIAZOLE FORMATION | - |
| dc.subject.keywordPlus | ANTICONVULSANT ACTIVITY | - |
| dc.subject.keywordPlus | ORGANIC-SYNTHESIS | - |
| dc.subject.keywordPlus | DRUG DISCOVERY | - |
| dc.subject.keywordPlus | SERIES | - |
| dc.subject.keywordPlus | INHIBITORS | - |
| dc.subject.keywordPlus | DESIGN | - |
| dc.subject.keywordAuthor | solid-phase | - |
| dc.subject.keywordAuthor | BOMBA | - |
| dc.subject.keywordAuthor | thiosemicarbazide | - |
| dc.subject.keywordAuthor | 1,3,4-thiadiazole | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
